Dr. Niloofar Piri, MD

Dr. Piri practices at SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri.

Dr. Piri's NPI, 1225428980, was assigned on February 2, 2015. Dr. Piri holds Missouri license 2020017646.

Dr. Piri's primary practice is SLUCare Physician Group Dermatology Pathology, at 1225 S Grand Blvd, 3rd Floor, Saint Louis, MO 63104. The practice phone is (314) 617-2709.

Dr. Piri's primary practice is SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri. Dr. Piri is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Piri to 1 more clinical lab and 1 group practice or clinic, each named with a free account. Dr. Piri's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Piri practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Piri's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dmand AI has Dr. Piri's licenses on file in 2 states: Missouri and Kentucky.

CMS data shows 1,140 Medicare services from Dr. Piri across 6 procedure codes in 2024, for 137 Medicare patients. Medicare paid $39,718 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Piri in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Piri's median patient age at 68, with 54% women.

In 2024, Dr. Piri wrote 24 Medicare Part D claims for 12 patients. 63% of them were for generic drugs. They cover 2 drugs, with $1,886 in total drug cost. In 2021, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Piri for performance year 2024, reported as part of a group. Dr. Piri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Piri, published from 2014 to 2023. 2021 was the busiest year, with 4. The most frequent topics are Cell Proliferation, Macular Degeneration and Mice, Inbred C57BL. Dr. Piri has published most often in J Ophthalmic Vis Res. Dr. Piri's most frequent co-authors are Shlomit Schaal, MD, PhD, Nisarg Chhaya and Jacob D. Grodsky, MD.

CMS Open Payments shows 34 general payments to Dr. Piri from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Alcon Laboratories Inc paid the most, $826.